Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
Clinical trial NCT02603107 · COMPLETED
Trial details
- NCT number
- NCT02603107
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-20
- Primary completion
- 2017-05-15
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.